
Sign up to save your podcasts
Or
If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
4.5
1212 ratings
If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
270 Listeners
835 Listeners
144 Listeners
687 Listeners
210 Listeners
1,060 Listeners
174 Listeners
253 Listeners
5 Listeners
27 Listeners
73 Listeners
3,358 Listeners
64 Listeners
193 Listeners
3,104 Listeners
6 Listeners
14 Listeners
53 Listeners
993 Listeners
1,123 Listeners
59 Listeners
9 Listeners
14 Listeners
45 Listeners
36 Listeners
467 Listeners
1 Listeners
3 Listeners
5 Listeners
7 Listeners
187 Listeners